Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 15, 2007

Rules-Based Medicine Recieves Grant to Develop a Test for Neonatal Sepsis

  • The NIH awarded Rules-Based Medicine (RBM) fast track funding of $849,000 to develop a diagnostic test for neonatal sepsis.

    The company will collaborate with the University of New Mexico (UNM) in Albuquerque. UNM will provide samples from their neonatal intensive care ward.

    RBM will perform all the testing and statistical analysis. The company will use its HumanMAP® platform to characterize and validate a pattern of biomarkers that can detect early signs of infection in newborns.

    In a preliminary study, according to RBM, data indicated that a sensitive, specific diagnostic is possible where no predicate test exists today.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »